These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3485440)
1. In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells. Langhoff E; Olgaard K Br J Clin Pharmacol; 1986 Feb; 21(2):125-9. PubMed ID: 3485440 [TBL] [Abstract][Full Text] [Related]
2. The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures. Langhoff E; Olgaard K; Ladefoged J Int J Immunopharmacol; 1987; 9(4):469-73. PubMed ID: 3497887 [TBL] [Abstract][Full Text] [Related]
3. The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cells. Langhoff E; Ladefoged J; Dickmeiss E Int J Immunopharmacol; 1985; 7(4):483-9. PubMed ID: 3876294 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone. Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects. Babadjanova G; Allolio B; Vollmer M; Reincke M; Schulte HM Eur J Clin Pharmacol; 1996; 51(1):53-7. PubMed ID: 8880052 [TBL] [Abstract][Full Text] [Related]
6. Suppression of intestinal mucosal natural killer cells by corticosteroids. Van Ierssel AJ; Mieremet-Ooms MA; Van der Zon JM; Van Hogezand RA; Griffioen G; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 1997 Apr; 11(2):347-53. PubMed ID: 9146774 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of deflazacort - a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisone. Hahn BH; Pletscher LS; Muniain M J Rheumatol; 1981; 8(5):783-90. PubMed ID: 6458701 [TBL] [Abstract][Full Text] [Related]
8. Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Markham A; Bryson HM Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761 [TBL] [Abstract][Full Text] [Related]
9. Rat diaphragm contractility and histopathology are affected differently by low dose treatment with methylprednisolone and deflazacort. Dekhuijzen PN; Gayan-Ramirez G; Bisschop A; de Bock V; Dom R; Bouillon R; Decramer M Eur Respir J; 1995 May; 8(5):824-30. PubMed ID: 7656957 [TBL] [Abstract][Full Text] [Related]
10. Effects of prednisolone and deflazacort on osteocalcin metabolism in sheep. O'Connell SL; Tresham J; Fortune CL; Farrugia W; McDougall JG; Scoggins BA; Wark JD Calcif Tissue Int; 1993 Aug; 53(2):117-21. PubMed ID: 8402319 [TBL] [Abstract][Full Text] [Related]
11. Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells. Canalis E; Avioli L J Bone Miner Res; 1992 Sep; 7(9):1085-92. PubMed ID: 1414501 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes. Guenther HL; Felix R; Fleisch H Calcif Tissue Int; 1984 Mar; 36(2):145-52. PubMed ID: 6430498 [TBL] [Abstract][Full Text] [Related]
13. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens. Di Munno O; Imbimbo B; Mazzantini M; Milani S; Occhipinti G; Pasero G J Rheumatol; 1995 Aug; 22(8):1492-8. PubMed ID: 7473472 [TBL] [Abstract][Full Text] [Related]
14. Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies. Scudeletti M; Pende D; Barabino A; Imbimbo B; Grifoni V; Indiveri F Adv Exp Med Biol; 1984; 171():335-44. PubMed ID: 6232833 [TBL] [Abstract][Full Text] [Related]
15. Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease. van Ierssel GJ; Mieremet-Ooms MA; van der Zon AM; van Hogezand RA; Wagtmans MJ; van der Sluys Veer A; Lamers CB; Verspaget HW Immunopharmacology; 1996 Sep; 34(2-3):97-104. PubMed ID: 8886853 [TBL] [Abstract][Full Text] [Related]
16. Deflazacort versus methylprednisolone in polymyalgia rheumatica. Sáez Barcelona JA; Carmona Martín MM; Navarro López V J Rheumatol; 1996 Jul; 23(7):1306-7. PubMed ID: 8823716 [No Abstract] [Full Text] [Related]
17. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas. Petri IB; Szekeres E; Varga E; Berek I; Molnár J; Berek L; Kawase M; Motohashi N Anticancer Res; 1996; 16(3A):1247-50. PubMed ID: 8702245 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the in vitro effects of glucocorticosteroids on NK cell activity. Pedersen BK; Beyer JM Allergy; 1986 Apr; 41(3):220-4. PubMed ID: 2424334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]